Tenofovir Disoproxil Fumarate + Emtricitabine + Cobicistat + ElvitegravirThird Party Manufacturing in India
Looking to get Tenofovir Disoproxil Fumarate + Emtricitabine + Cobicistat + Elvitegravir manufactured under your brand? Our WHO-GMP certified partner facilities support PCD franchise partners and global export opportunities structured across 25+ countries.
Mechanism of Action
Tenofovir Disoproxil Fumarate + Emtricitabine + Cobicistat + Elvitegravir works through a multi-pronged mechanism combining two NRTIs, a pharmacokinetic enhancer, and an integrase strand transfer inhibitor. Elvitegravir blocks HIV integrase to prevent viral DNA integration into host genomes, Tenofovir and Emtricitabine induce viral DNA chain termination via reverse transcriptase inhibition, and Cobicistat selectively inhibits human CYP3A enzymes. It targets these diverse pathways to help the body maximize intracellular concentrations of the active antiviral agents. Unlike multi-pill regimens, this single-tablet configuration optimizes adherence. It is highly effective and well-tolerated.
Therapeutic Uses & Indications
Therapeutic Uses
- Complete HIV-1 Treatment: Functions as a complete, standalone single-tablet regimen for antiretroviral-naive HIV-1 infected adults.
- Viral Suppression Maintenance: Replaces stable antiretroviral regimens in patients experiencing excellent virologic control without drug resistance mutations.
- Immune Restoration Support: Promotes steady recovery of CD4+ T-cell counts by suppressing plasma HIV-1 RNA levels.
Why Manufacturers Choose Tenofovir Disoproxil Fumarate + Emtricitabine + Cobicistat + Elvitegravir
Tenofovir Disoproxil Fumarate + Emtricitabine + Cobicistat + Elvitegravir third party manufacturing in India represents the peak of complex, multi-component B2B formulation capabilities. Compounding four disparate active ingredients into a single monolithic tablet requires outstanding analytical validation and advanced granulation engineering. Our partner facilities maintain world-class, dedicated antiviral wings fully certified by WHO-GMP guidelines, providing reliable security, scale, and cross-contamination protection.
Dosage Forms We Manufacture
Frequently Asked Questions
What is the minimum order quantity for Tenofovir Disoproxil Fumarate + Emtricitabine + Cobicistat + Elvitegravir?
What dosage forms of Tenofovir Disoproxil Fumarate + Emtricitabine + Cobicistat + Elvitegravir can you manufacture?
Are your manufacturing facilities WHO-GMP certified?
Can you manufacture Tenofovir Disoproxil Fumarate + Emtricitabine + Cobicistat + Elvitegravir for export?
What grade standards do you follow for Tenofovir Disoproxil Fumarate + Emtricitabine + Cobicistat + Elvitegravir?
Get Tenofovir Disoproxil Fumarate + Emtricitabine + Cobicistat + Elvitegravir made under your brand
- WHO-GMP certified facilities
- Quote within 24 hours
- MOQ from 10,000 tablets per batch
+91 9689237122 · replies within hours
Our Manufacturing Capabilities
- WHO-GMP Certified Partner Plants
- 25+ years of pharma industry experience
- PCD Franchise with monopoly rights
- Export support across 25+ countries
- Small batch to commercial scale
- Custom formulation development
Packaging Options
High-barrier induction-sealed HDPE bottles containing integrated silica gel moisture absorbers, packed in protective cartons.
Start Manufacturing Tenofovir Disoproxil Fumarate + Emtricitabine + Cobicistat + Elvitegravir Today
Celesta Healthcare provides WHO-GMP certified third-party manufacturing for Tenofovir Disoproxil Fumarate + Emtricitabine + Cobicistat + Elvitegravir across all dosage forms. PCD franchise and export orders welcome.